A method of preventing dementia in a patient with Parkinson's disease or of improving or restoring cognitive function of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said cognitive function, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
When dosing children, be sure to consult a pediatric dosing calculator such as this one
PLoS Med (2008) 5(3):e54.10.1371/journal.pmed.0050054 119 KaserALeeAHFrankeAGlickmanJNZeissigSTilgHet alXBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease
(2021) 65:e170320
Esa selectividad es la razn clnica por la que este stack se prefiere hoy
La semaglutida , el principio activo en Ozempic y en Wegovy y Rybelsus
